Rhabdomyosarcoma

Open Access
Clinicopathological Characteristics, Survival Outcomes, and Prognostic Factors in Adult Patients With Sinonasal Rhabdomyosarcoma: Insights from a Retrospective Cohort Study
MONIKA DURZYNSKA, FLORENTINO LUCIANO CAETANO DOS SANTOS and IRMINA MARIA MICHALEK

Anticancer Research October 2023, 43 (10) 4517-4524; DOI: https://doi.org/10.21873/anticanres.16645
Open Access
Epigallocatechin Gallate Inhibits Cell Growth and Hedgehog Signalling in Human Rhabdomyosarcoma Cell Lines
BENJAMIN F.B. MAYER, MATIAS J. STAGNO, JÖRG FUCHS, STEVEN W. WARMANN and EVI SCHMID

Anticancer Research March 2023, 43 (3) 1025-1030; DOI: https://doi.org/10.21873/anticanres.16247
You have access
Somatic Transformation in Metastatic Testicular Germ Cell Tumours – A Different Disease Entity
ANAND SHARMA, CONSTANTINE ALIFRANGIS, MARINA MILIC, MARCIA HALL, NIKHIL VASDEV, PETER WILSON, ANDREW GOGBASHIAN, DAVID HROUDA, DANIEL BERNEY and JONATHAN SHAMASH

Anticancer Research September 2019, 39 (9) 4911-4916; DOI: https://doi.org/10.21873/anticanres.13678
You have access
Inhibition of Chemoresistance in Primary Tumor Cells by Camellia sinensis non fermentatum Extract Noviphenone (NPE®)
CHIARA GIORGI, URS E. GASSER, MARION E. LAFONT, HANS E. HOLZGANG and VERENA FONTANA THALHAMMER

Anticancer Research August 2019, 39 (8) 4101-4110; DOI: https://doi.org/10.21873/anticanres.13568
You have access
Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment
YEN-TING LIU, CHUN-WEI WANG, RUEY-LONG HONG and SUNG-HSIN KUO

Anticancer Research March 2019, 39 (3) 1355-1364; DOI: https://doi.org/10.21873/anticanres.13249
You have access
Combination of Osthole and Cisplatin Against Rhabdomyosarcoma TE671 Cells Yielded Additive Pharmacologic Interaction by Means of Isobolographic Analysis
AGATA JARZĄB, JAROGNIEW ŁUSZCZKI, MAŁGORZATA GUZ, KRYSTYNA SKALICKA-WOŹNIAK, MARTA HAŁASA, JOLANTA SMOK-KALWAT, KRZYSZTOF POLBERG and ANDRZEJ STEPULAK

Anticancer Research January 2018, 38 (1) 205-210;
You have access
Efficacy In Vitro of Caffeine and Valproic Acid on Patient-Derived Undifferentiated Pleomorphic Sarcoma and Rhabdomyosarcoma Cell Lines
KENTARO IGARASHI, KEI KAWAGUCHI, TASUKU KIYUNA, TAKASHI MURAKAMI, SHINJI MIWA, SCOTT D. NELSON, SARAH M. DRY, YUNFENG LI, ARUN S. SINGH, HIROAKI KIMURA, KATSUHIRO HAYASHI, NORIO YAMAMOTO, HIROYUKI TSUCHIYA, FRITZ C. EILBER and ROBERT M. HOFFMAN

Anticancer Research August 2017, 37 (8) 4081-4084;
You have access
Pleomorphic Rhabdomyosarcoma of the Uterus – Case Report and a Systematic Review of the Literature
SARA ALAVI, LENA ECKES, ROBERT KRATSCHELL, ELIANE TABEA TAUBE, FRIEDERIKE ROSSECK, GERO WIENERS and JALID SEHOULI

Anticancer Research May 2017, 37 (5) 2509-2514;
You have access
Additive Interaction of Cisplatin and Histone Deacetylase Inhibitors Combined Treatment in Rhabdomyosarcoma Cells – An Isobolographic Analysis
AGATA JARZĄB, JAROGNIEW J. ŁUSZCZKI, MAŁGORZATA GUZ, EWELINA GUMBAREWICZ, KRZYSZTOF POLBERG and ANDRZEJ STEPULAK

Anticancer Research March 2017, 37 (3) 1067-1074;
You have access
Ifosfamide and Etoposide Chemotherapy in the Treatment of Recurrent/Refractory Rhabdomyosarcoma in Adults
SHINSUKE SASADA, MAKOTO KODAIRA, TATSUNORI SHIMOI, AKIHIKO SHIMOMURA, MAYU YUNOKAWA, KAN YONEMORI, CHIKAKO SHIMIZU, YASUHIRO FUJIWARA and KENJI TAMURA

Anticancer Research May 2016, 36 (5) 2429-2432;

Main menu

User menu

Search

Rhabdomyosarcoma

Pages